Colorectal Cancer Trial, Recruiting NCT06757192 Sponsor: Massachusetts General Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06757192
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For Patients:

  • You are between 45 and 54 years old
  • You are a patient at the health center
  • You are willing and able to give verbal or written consent to take part

For Health Center Staff:

  • You are 18 years old or older
  • You work at the health center
  • You are involved in colorectal cancer screening processes at the health center
  • You are willing and able to give verbal or written consent to take part

Who may not be able to join:

For Patients:

  • You have personally been diagnosed with colorectal cancer (bowel cancer) in the past
  • A close family member has been diagnosed with colorectal cancer (bowel cancer)
  • You have a history of inflammatory bowel disease (such as Crohn's disease or ulcerative colitis) or a condition that puts you at high risk of certain cancers (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Adjoa Anyane-Yeboa, MD, MPH, Massachusetts General Hospital

Phone: (617) 726-6609

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 June 2025
Est. completion
31 August 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Measurement of acceptability and feasibility of implementation strategies

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov